Wiley T L, Poole C P, Gookin K S, Wiser W L, Morrison J C
Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson 39216.
Int J Gynaecol Obstet. 1989 Feb;28(2):171-5. doi: 10.1016/0020-7292(89)90478-5.
Prostaglandin E2 (PGE2) suppositories have been shown to be active contractile agents and are effective in uterine evacuation for mid-trimester abortion or fetal demise. In this study, 85 patients were treated with vaginal PGE2 suppositories. When laminaria were used in patients with closed cervices, and compared to those who had minimal cervical dilatation, there was no difference in the time from induction to expulsion. Ninety-three percent of the 85 patients aborted successfully within 24 h. In each of the seven "failures", three or less suppositories were used prior to a dilatation and evacuation procedure. In this study, 81% of the abortions were complete, and in one-third of the remaining patients dilatation and curettage was performed just after delivery of the fetus. The incidence of minor side-effects ranged from 12 to 21%, and there were no major complications. It is concluded that the use of vaginal prostaglandin E2 suppositories for induction of mid-trimester abortion or fetal demise in the third trimester is safe and effective.
前列腺素E2(PGE2)栓剂已被证明是有效的宫缩剂,在中期妊娠流产或胎儿死亡后用于子宫排空时效果显著。在本研究中,85例患者接受了阴道PGE2栓剂治疗。对于宫颈未扩张的患者使用海藻棒时,与宫颈轻度扩张的患者相比,从引产到排出的时间并无差异。85例患者中有93%在24小时内成功流产。在7例“失败”病例中,每例在扩张刮宫术前使用的栓剂均不超过3枚。本研究中,81%的流产为完全流产,其余患者中有三分之一在胎儿娩出后立即进行了扩张刮宫术。轻微副作用的发生率在12%至21%之间,未出现严重并发症。结论是,阴道使用前列腺素E2栓剂用于中期妊娠流产引产或晚期妊娠胎儿死亡引产是安全有效的。